Proteins > Sphingosine 1-phosphate receptor 1
Page last updated: 2024-08-07 16:10:19
Sphingosine 1-phosphate receptor 1
A sphingosine 1-phosphate receptor 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P21453]
Synonyms
S1P receptor 1;
S1P1;
Endothelial differentiation G-protein coupled receptor 1;
Sphingosine 1-phosphate receptor Edg-1;
S1P receptor Edg-1
Research
Bioassay Publications (49)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (22.45) | 29.6817 |
2010's | 32 (65.31) | 24.3611 |
2020's | 6 (12.24) | 2.80 |
Compounds (16)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
fingolimod | Homo sapiens (human) | IC50 | 0.7219 | 2 | 2 |
sew2871 | Homo sapiens (human) | IC50 | 0.0370 | 2 | 2 |
sphingosine 1-phosphate | Homo sapiens (human) | IC50 | 0.0008 | 6 | 6 |
fty 720p | Homo sapiens (human) | IC50 | 0.0001 | 4 | 4 |
fty 720p | Homo sapiens (human) | Ki | 0.2117 | 1 | 5 |
jte 013 | Homo sapiens (human) | IC50 | 1.0000 | 2 | 2 |
ponesimod | Homo sapiens (human) | IC50 | 0.0126 | 1 | 1 |
fty 720p | Homo sapiens (human) | IC50 | 0.0008 | 3 | 3 |
fty 720p | Homo sapiens (human) | Ki | 0.2066 | 1 | 5 |
Drugs with Activation Measurements
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
fty 720p | Homo sapiens (human) | Activity | 0.0072 | 2 | 2 |
The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO.Journal of medicinal chemistry, , 12-23, Volume: 64, Issue:24, 2021
Spiro-1-benzofuranpiperidinylalkanoic acids as a novel and selective sphingosine S1PBioorganic & medicinal chemistry letters, , 02-01, Volume: 28, Issue:3, 2018
Late-stage optimization of a tercyclic class of S1P3-sparing, S1P1 receptor agonists.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 26, Issue:2, 2016
Modulators of the Sphingosine 1-phosphate receptor 1.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Quinolinone-based agonists of S1P₁: use of a N-scan SAR strategy to optimize in vitro and in vivo activity.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 22, Issue:1, 2012
Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.Journal of medicinal chemistry, , Aug-11, Volume: 48, Issue:16, 2005
A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.Journal of medicinal chemistry, , Dec-30, Volume: 47, Issue:27, 2004
An update on sphingosine-1-phosphate receptor 1 modulators.Bioorganic & medicinal chemistry letters, , 12-15, Volume: 28, Issue:23-24, 2018
Quinolinone-based agonists of S1P₁: use of a N-scan SAR strategy to optimize in vitro and in vivo activity.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 22, Issue:1, 2012
Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS.ACS medicinal chemistry letters, , Feb-10, Volume: 2, Issue:2, 2011
A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.Journal of medicinal chemistry, , Dec-30, Volume: 47, Issue:27, 2004
Synthesis and evaluation of highly selective quinazoline-2,4-dione ligands for sphingosine-1-phosphate receptor 2.RSC medicinal chemistry, , Feb-23, Volume: 13, Issue:2, 2022
Design and synthesis of pyrazolopyridine derivatives as sphingosine 1-phosphate receptor 2 ligands.Bioorganic & medicinal chemistry letters, , 02-01, Volume: 28, Issue:3, 2018
Late-stage optimization of a tercyclic class of S1P3-sparing, S1P1 receptor agonists.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 26, Issue:2, 2016
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.ACS medicinal chemistry letters, , Dec-11, Volume: 5, Issue:12, 2014
Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis.ACS medicinal chemistry letters, , Oct-10, Volume: 4, Issue:10, 2013
Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 23, Issue:2, 2013
Quinolinone-based agonists of S1P₁: use of a N-scan SAR strategy to optimize in vitro and in vivo activity.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 22, Issue:1, 2012
Stereochemistry-activity relationship of orally active tetralin S1P agonist prodrugs.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 20, Issue:7, 2010
2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists.Journal of medicinal chemistry, , May-27, Volume: 53, Issue:10, 2010
Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 20, Issue:8, 2010
Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 19, Issue:2, 2009
Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 17, Issue:2, 2007
Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.Bioorganic & medicinal chemistry letters, , Aug-01, Volume: 15, Issue:15, 2005
Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.Bioorganic & medicinal chemistry letters, , Jun-21, Volume: 14, Issue:12, 2004
A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.Journal of medicinal chemistry, , Dec-30, Volume: 47, Issue:27, 2004
Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists.Bioorganic & medicinal chemistry letters, , Oct-04, Volume: 14, Issue:19, 2004
Synthesis of para-alkyl aryl amide analogues of sphingosine-1-phosphate: discovery of potent S1P receptor agonists.Bioorganic & medicinal chemistry letters, , Oct-20, Volume: 13, Issue:20, 2003
Discovery of Novel Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis.Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
Bicyclic Ligand-Biased Agonists of S1PJournal of medicinal chemistry, , 02-11, Volume: 64, Issue:3, 2021
S1PBioorganic & medicinal chemistry letters, , 06-01, Volume: 30, Issue:11, 2020
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.ACS medicinal chemistry letters, , Mar-10, Volume: 7, Issue:3, 2016
Discovery of oxazole and triazole derivatives as potent and selective S1P(1) agonists through pharmacophore-guided design.European journal of medicinal chemistry, , Oct-06, Volume: 85, 2014
Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis.ACS medicinal chemistry letters, , Oct-10, Volume: 4, Issue:10, 2013
Removal of sphingosine 1-phosphate receptor-3 (S1P(3)) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P(1) agonists with reduced effect on heart rate.Journal of medicinal chemistry, , Apr-22, Volume: 53, Issue:8, 2010
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists.Bioorganic & medicinal chemistry, , Jan-15, Volume: 15, Issue:2, 2007
Asymmetric synthesis and biological evaluation of the enantiomeric isomers of the immunosuppressive FTY720-phosphate.Bioorganic & medicinal chemistry, , Jan-17, Volume: 13, Issue:2, 2005
Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.Journal of medicinal chemistry, , Aug-11, Volume: 48, Issue:16, 2005
Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.Bioorganic & medicinal chemistry letters, , Aug-01, Volume: 15, Issue:15, 2005
Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.Bioorganic & medicinal chemistry letters, , Jun-21, Volume: 14, Issue:12, 2004
A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.Journal of medicinal chemistry, , Dec-30, Volume: 47, Issue:27, 2004
Design, synthesis, and in vitro bioactivity evaluation of fluorine-containing analogues for sphingosine-1-phosphate 2 receptor.Bioorganic & medicinal chemistry, , 08-15, Volume: 27, Issue:16, 2019
Design and synthesis of pyrazolopyridine derivatives as sphingosine 1-phosphate receptor 2 ligands.Bioorganic & medicinal chemistry letters, , 02-01, Volume: 28, Issue:3, 2018
Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1.Bioorganic & medicinal chemistry letters, , 10-15, Volume: 28, Issue:19, 2018
2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists.Journal of medicinal chemistry, , May-27, Volume: 53, Issue:10, 2010
Novel Potent Selective Orally Active S1P5 Receptor Antagonists.ACS medicinal chemistry letters, , Mar-11, Volume: 12, Issue:3, 2021
Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1PJournal of medicinal chemistry, , 03-14, Volume: 62, Issue:5, 2019
Kinase-independent phosphoramidate S1PBioorganic & medicinal chemistry letters, , 03-15, Volume: 27, Issue:6, 2017
Late-stage optimization of a tercyclic class of S1P3-sparing, S1P1 receptor agonists.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 26, Issue:2, 2016
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.Journal of medicinal chemistry, , Feb-11, Volume: 59, Issue:3, 2016
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series.Journal of medicinal chemistry, , Mar-24, Volume: 59, Issue:6, 2016
Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P₁ agonists.Bioorganic & medicinal chemistry, , Aug-01, Volume: 22, Issue:15, 2014
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.ACS medicinal chemistry letters, , Dec-11, Volume: 5, Issue:12, 2014
Identification of benzoxazole analogs as novel, S1P(3) sparing S1P(1) agonists.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 22, Issue:12, 2012
Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist.European journal of medicinal chemistry, , Volume: 51, 2012
Novel immunomodulators based on an oxazolin-2-one-4-carboxamide scaffold.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 22, Issue:1, 2012
Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS.ACS medicinal chemistry letters, , Feb-10, Volume: 2, Issue:2, 2011
Discovery of a brain-penetrant S1P₃-sparing direct agonist of the S1P₁ and S1P₅ receptors efficacious at low oral dose.Journal of medicinal chemistry, , Oct-13, Volume: 54, Issue:19, 2011
Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist.ACS medicinal chemistry letters, , May-12, Volume: 2, Issue:5, 2011
Stereochemistry-activity relationship of orally active tetralin S1P agonist prodrugs.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 20, Issue:7, 2010
Asymmetric synthesis and biological evaluation of the enantiomeric isomers of the immunosuppressive FTY720-phosphate.Bioorganic & medicinal chemistry, , Jan-17, Volume: 13, Issue:2, 2005
Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.Journal of medicinal chemistry, , Aug-11, Volume: 48, Issue:16, 2005
Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist.European journal of medicinal chemistry, , Volume: 51, 2012
Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 22, Issue:4, 2012
Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P₃-sparing S1P₁ agonists.Bioorganic & medicinal chemistry letters, , May-01, Volume: 22, Issue:9, 2012
Enables
This protein enables 5 target(s):
Target | Category | Definition |
G protein-coupled receptor binding | molecular function | Binding to a G protein-coupled receptor. [GOC:ceb, GOC:dph] |
G protein-coupled receptor activity | molecular function | Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. [GOC:bf, http://www.iuphar-db.org, Wikipedia:GPCR] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
sphingosine-1-phosphate receptor activity | molecular function | Combining with the sphingolipid sphingosine-1-phosphate (S1P), and transmitting the signal across the membrane by activating an associated G-protein. [GOC:bf, PMID:12728273, Wikipedia:S1PR1] |
sphingolipid binding | molecular function | Binding to a sphingolipid, a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid). [ISBN:0198506732] |
Located In
This protein is located in 6 target(s):
Target | Category | Definition |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
endosome | cellular component | A vacuole to which materials ingested by endocytosis are delivered. [ISBN:0198506732, PMID:19696797] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
external side of plasma membrane | cellular component | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. [GOC:dos, GOC:tb] |
intracellular membrane-bounded organelle | cellular component | Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. [GOC:go_curators] |
membrane raft | cellular component | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. [PMID:16645198, PMID:20044567] |
Active In
This protein is active in 2 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
Involved In
This protein is involved in 30 target(s):
Target | Category | Definition |
blood vessel maturation | biological process | A developmental process, independent of morphogenetic (shape) change, that is required for a blood vessel to attain its fully functional state. [GOC:dph] |
cardiac muscle tissue growth involved in heart morphogenesis | biological process | The developmental growth of cardiac muscle tissue that contributes to the shaping of the heart. [GOC:mtg_heart] |
sphingosine-1-phosphate receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway initiated by sphingosine-1-phosphate binding to its receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:ascb_2009, GOC:signaling, PMID:14592418, PMID:22001186, Reactome:R-HSA-419428] |
chemotaxis | biological process | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). [ISBN:0198506732] |
cell adhesion | biological process | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. [GOC:hb, GOC:pf] |
G protein-coupled receptor signaling pathway | biological process | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. [GOC:bf, GOC:mah, PMID:16902576, PMID:24568158, Wikipedia:G_protein-coupled_receptor] |
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the inhibition of adenylyl cyclase activity and a subsequent decrease in the intracellular concentration of cyclic AMP (cAMP). [GOC:dph, GOC:mah, GOC:signaling, GOC:tb, ISBN:0815316194] |
phospholipase C-activating G protein-coupled receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of phospholipase C (PLC) and a subsequent increase in the intracellular concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG). [GOC:dph, GOC:mah, GOC:signaling, GOC:tb, ISBN:0815316194] |
brain development | biological process | The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.). [GOC:dph, GOC:jid, GOC:tb, UBERON:0000955] |
cell population proliferation | biological process | The multiplication or reproduction of cells, resulting in the expansion of a cell population. [GOC:mah, GOC:mb] |
cell migration | biological process | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. [GOC:cjm, GOC:dph, GOC:ems, GOC:pf, Wikipedia:Cell_migration] |
transmission of nerve impulse | biological process | The neurological system process in which a signal is transmitted through the nervous system by a combination of action potential propagation and synaptic transmission. [GOC:curators, ISBN:0815316194] |
lamellipodium assembly | biological process | Formation of a lamellipodium, a thin sheetlike extension of the surface of a migrating cell. [GOC:mah, ISBN:0815316194] |
actin cytoskeleton organization | biological process | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. [GOC:dph, GOC:jl, GOC:mah] |
regulation of cell adhesion | biological process | Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix. [GOC:mah] |
neuron differentiation | biological process | The process in which a relatively unspecialized cell acquires specialized features of a neuron. [GOC:mah] |
positive regulation of cell migration | biological process | Any process that activates or increases the frequency, rate or extent of cell migration. [GOC:go_curators] |
regulation of bone mineralization | biological process | Any process that modulates the frequency, rate or extent of bone mineralization. [GOC:go_curators] |
leukocyte chemotaxis | biological process | The movement of a leukocyte in response to an external stimulus. [GOC:add, GOC:jl] |
regulation of bone resorption | biological process | Any process that modulates the frequency, rate or extent of bone tissue loss (resorption). [GOC:ai] |
endothelial cell differentiation | biological process | The process in which a mesodermal, bone marrow or neural crest cell acquires specialized features of an endothelial cell, a thin flattened cell. A layer of such cells lines the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium. [CL:0000115, GOC:go_curators] |
positive regulation of transcription by RNA polymerase II | biological process | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. [GOC:go_curators, GOC:txnOH] |
positive regulation of smooth muscle cell proliferation | biological process | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. [CL:0000192, GOC:ebc] |
positive regulation of positive chemotaxis | biological process | Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical. [GOC:ai] |
negative regulation of stress fiber assembly | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the assembly a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts. [GOC:ai] |
heart trabecula morphogenesis | biological process | The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue. [GOC:dph] |
T cell migration | biological process | The movement of a T cell within or between different tissues and organs of the body. [CL:0000084, GOC:BHF, GOC:mah] |
angiogenesis | biological process | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. [ISBN:0878932453] |
regulation of metabolic process | biological process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism. [GOC:go_curators] |
adenylate cyclase-activating G protein-coupled receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of adenylyl cyclase activity which results in an increase in the intracellular concentration of cyclic AMP (cAMP). This pathway is negatively regulated by phosphodiesterase, which cleaves cAMP and terminates the signaling. [GOC:dph, GOC:mah, GOC:signaling, GOC:tb, ISBN:0815316194] |